News

Vikrant Shrotriya said Human Mixtard is not being discontinued in India and will be supplied in vial presentation ...
The Tata-Cornell Institute project aims to strengthen Indian food value chains for climate resilience and nutritious diets.
Novonesis, a world-leading biosolutions company, co-hosted its 'Unlocking Value for a Sustainable Future' Partnering Day 2025 ...
The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S.; in Germany, it’s $328. The U.S. price for Keytruda, a cancer treatment, is $191,000 ...
Q1 2025 Management View Mike Exton, Chief Executive Officer, highlighted a pivotal exclusive license agreement with Novo Nordisk for LX9851, stating "this agreement grants Novo an exclusive worldwide ...
A pronouncement from President Trump about the category drove their share prices down, although not to bargain-basement ...
It's likely that Trump was referring to Elon Musk in the quoted tweet. Musk has publicly admitted to using weight-loss drugs ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
It would be another two years before French researchers would identify a retrovirus as the cause of AIDS, or acquired immunodeficiency syndrome, according to the CDC. It would be another three years ...
The president claimed his “most-favored nation” proposal would reduce some pharmaceutical prices by as much as 80%, but the ...
The Kassø eMethanol facility in Aabenraa, Denmark, has been officially inaugurated and is now supplying eMethanol to ...
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will summarize the bulls’ thesis on NVO.